Acute hepatitis due to montelukast [5];Hepatitis aguda por montelukast

Medicina Clinica

Volumn 120, Issue 6, 2003, Pages 239-

  Romero Gómez, Manuel ^a   Sánchez Muñoz, Diego ^a   Castilla, Luis ^a   Castro, Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST; ZAFIRLUKAST;

ADULT; ASTHMA; CASE REPORT; CLINICAL FEATURE; ECHOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; HEPATITIS; HEPATITIS A VIRUS; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HUMAN; LABORATORY TEST; LETTER; LIVER TOXICITY; SEROLOGY;

EID: 0037460502     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13043325     Document Type: Letter

References (8)

1. Actis GC, Morgando A, Lagget M, David E, Rizzetto M. Zafirlukast-related hepatitis: report of a further case. J Hepatol 2001;35:539-41.
2. Molés JR, Primo J, Fernández JM, Hinojosa JE. Acute hepatocellular injury associated with zafirlukast. J Hepatol 2001;35:541-2.
3. Romero-Gómez M, Otero MA, Suárez-García E, García Díaz E, Fobelo MJ, Castro-Fernández M. Acute hepatitis related to omeprazole. Am J Gastroenterol 1999;94:1119-20.
4. Singulair (montelukast sodium). Product circular, 1998.
5. Trujillo-Santos AJ, Peralta-Camisuli L, García de Lucas MD, García Alegría J. Síndrome de Churg-Strauss relacionado con montelukast. Med Clin (Barc) 2000;115:599.
6. Tuggey JM, Hosker HSR. Churg-Strauss syndrome associated with montelukast therapy. Thorax 2000;55:805-6.
7. Sabadell C, Jolis R, Canalías J. Síndrome de Churg-Strauss asociado al tratamiento con montelukast. Med Clin (Barc) 2001;117:159.
8. Chiba M, Xu X, Nishime JA, Balani SK, Lin JH. Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans. Drug Metab Dispos 1997;25:1022-31.